These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 32449143

  • 1. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
    Guo S, Zhang J, Wei C, Lu Z, Cai R, Pan D, Zhang H, Liang B, Zhang Z.
    Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
    [Abstract] [Full Text] [Related]

  • 2. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.
    ShuoWang, Song Z, Gong X, Ou C, Zhang W, Wang J, Yao C, Qin S, Yan B, Li Q, Wei K, Hou X, Zhou X, Miao J.
    J Ethnopharmacol; 2021 May 10; 271():113879. PubMed ID: 33524509
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
    Ye R, Dai N, He Q, Guo P, Xiang Y, Zhang Q, Hong Z, Zhang Q.
    Biomed Pharmacother; 2018 Sep 10; 105():962-973. PubMed ID: 30021391
    [Abstract] [Full Text] [Related]

  • 4. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
    Lin YT, Wang HC, Chuang HC, Hsu YC, Yang MY, Chien CY.
    J Mol Med (Berl); 2018 Dec 10; 96(12):1407-1418. PubMed ID: 30374682
    [Abstract] [Full Text] [Related]

  • 5. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
    Zhao YY, Tian Y, Zhang J, Xu F, Yang YP, Huang Y, Zhao HY, Zhang JW, Xue C, Lam MH, Yan L, Hu ZH, Dinglin XX, Zhang L.
    Drug Des Devel Ther; 2014 Dec 10; 8():1827-37. PubMed ID: 25336925
    [Abstract] [Full Text] [Related]

  • 6. Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma.
    Liu T, Sun Q, Li Q, Yang H, Zhang Y, Wang R, Lin X, Xiao D, Yuan Y, Chen L, Wang W.
    Mol Cancer Ther; 2015 Feb 10; 14(2):429-39. PubMed ID: 25504751
    [Abstract] [Full Text] [Related]

  • 7. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J, Wen B, Wang Y, Wu S, Zhang X, Gu Y, Wang Z, Wang J, Zhang W, Yong J.
    Biomed Pharmacother; 2020 Dec 10; 132():110898. PubMed ID: 33113432
    [Abstract] [Full Text] [Related]

  • 8. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
    Huang W, Zeng C, Liu J, Yuan L, Liu W, Wang L, Zhu H, Xu Y, Luo Y, Xie D, Jiang X, Ren C.
    Biochem Biophys Res Commun; 2019 Jun 18; 514(1):64-70. PubMed ID: 31023529
    [Abstract] [Full Text] [Related]

  • 9. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
    Cheng Y, Wang Q, Zhang Z, Zhao C, Zhou H, Xu J, Gu Q.
    Phytomedicine; 2022 Jul 18; 101():154133. PubMed ID: 35504052
    [Abstract] [Full Text] [Related]

  • 10. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
    Li Q, Ni W, Deng Z, Liu M, She L, Xie Q.
    Fundam Clin Pharmacol; 2017 Jun 18; 31(3):301-310. PubMed ID: 28078787
    [Abstract] [Full Text] [Related]

  • 11. Arnicolide D, from the herb Centipeda minima, Is a Therapeutic Candidate against Nasopharyngeal Carcinoma.
    Liu R, Dow Chan B, Mok DK, Lee CS, Tai WC, Chen S.
    Molecules; 2019 May 17; 24(10):. PubMed ID: 31108969
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y, Wang Y, Fan X, Song J, Wu H, Han J, Lu L, Weng X, Nie G.
    Biochem Biophys Res Commun; 2018 Sep 10; 503(3):1214-1220. PubMed ID: 30017199
    [Abstract] [Full Text] [Related]

  • 17. Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway.
    He J, Cai L, Chen Y, He Y, Wang M, Tang J, Guan H, Wang J, Peng X.
    Radiother Oncol; 2018 Oct 10; 129(1):30-37. PubMed ID: 29519627
    [Abstract] [Full Text] [Related]

  • 18. Preclinical efficacy and involvement of mTOR signaling in the mechanism of Orf virus against nasopharyngeal carcinoma cells.
    Huang Y, Gong K, Chen J, Deng H, Weng K, Wu H, Li K, Xiao B, Luo S, Hao W.
    Life Sci; 2022 Feb 15; 291():120297. PubMed ID: 35007565
    [Abstract] [Full Text] [Related]

  • 19. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
    Liang Y, Feng G, Wu L, Zhong S, Gao X, Tong Y, Cui W, Qin Y, Xu W, Xiao X, Zhang Z, Huang G, Zhou X.
    Drug Des Devel Ther; 2019 Feb 15; 13():1335-1345. PubMed ID: 31118570
    [Abstract] [Full Text] [Related]

  • 20. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
    Wang X, Jin Q, Wang X, Chen W, Cai Z.
    Cancer Biomark; 2019 Feb 15; 26(2):171-182. PubMed ID: 31403940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.